Diartis Pharmaceuticals Receives New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=259b1db1-9e11-460c-8996-b47f9f642665&Preview=1 - Date
2/16/2011 - Company Name
Diartis Pharmaceuticals - Mailing Address
500 Ellis St. Mountain View, CA 94043 - Company Description
Diartis is a biotechnology company founded to develop therapeutics for the treatment of metabolic diseases that address both significant unmet medical needs as well as large market opportunities. - Website
http://www.diartispharma.com - Transaction Type
Venture Equity - Transaction Amount
Undisclosed - Transaction Round
Undisclosed - Proceeds Purposes
The company will focus on moving this exciting compound rapidly through early clinical development. Given the dramatic rise in the number of people with type 2 diabetes, there is a significant market need for a longer acting form of the GLP-1 analog exenatide. - M&A Terms
- Venture Investor
Index Ventures - Venture Investor
Undisclosed
